Principal Investigators Michele Curatolo and Daniel Raftery have received notice of award for a project for 3 years from collaborator Merck & Co., Inc. Total award amount: $1,961,076.
Title: Metabolomics profiles of chronic low back pain and fibromyalgia
Description: The investigators aims to identify molecular pathways involved in the pathophysiology of chronic low back pain and fibromyalgia by applying metabolomics in thoroughly phenotyped patients; thereby facilitating the identification of novel phenotype-specific therapeutic targets and of candidate biomarkers.